Independent determinants of the Tei index in hypertensive patients with preserved left ventricular systolic function

Hisashi Masugata1, Shoichi Senda, Fuminori Goda

  • 1Department of Integrated Medicine, Kagawa University, Kagawa, Japan.

Insights

The Tei index, reflecting left ventricular function, may offer prognostic value in hypertensive patients. It appears linked to early diastolic dysfunction and heart remodeling, alongside the E/A ratio.

Area of Science:

  • Cardiology
  • Echocardiography
  • Hypertension Research

Background:

  • The Tei index assesses left ventricular (LV) systolic and diastolic function and has prognostic value in heart disease.
  • Transmitral E/A ratio also shows prognostic value in hypertensive patients.
  • The Tei index's utility in hypertensive patients without overt heart disease is understudied.

Purpose of the Study:

  • To compare the Tei index between hypertensive and normotensive patients.
  • To identify independent determinants of the Tei index in hypertensive patients with preserved LV systolic function.

Main Methods:

  • Doppler echocardiography was used to measure LV structural and functional parameters.
  • 319 patients with cardiovascular risk factors (hypertension, diabetes) and preserved LV systolic function (ejection fraction ≥ 55%) were studied.
  • Patients were divided into normotensive (n=100) and hypertensive (n=219) groups.

Main Results:

  • The Tei index correlated most closely with transmitral E velocity (r = -0.311, P < 0.001) in hypertensive patients.
  • Stepwise regression identified E velocity (β = -0.315, P < 0.001) and relative wall thickness (β = 0.262, P < 0.001) as independent determinants of the Tei index.
  • Hypertensive patients showed differences in Tei index compared to normotensive patients (implied, not explicitly stated as a result).

Conclusions:

  • The Tei index in hypertensive patients with preserved LV systolic function may primarily reflect early diastolic dysfunction and LV concentric remodeling.
  • The Tei index, along with the E/A ratio, may hold prognostic significance in hypertensive individuals.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...